肾移植受者 SARS-CoV-2 肺炎的免疫抑制治疗维持：一例报告。
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.
机构信息
Nephrology, Dialysis and Transplantation, University of Genoa and Policlinico San Martino, Genoa, Italy.
Infectious Diseases Unit, University of Genoa and Policlinico San Martino, Genoa, Italy.
出版信息
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
Abstract
The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2-infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.
摘要
全身炎症反应在确定感染 SARS-CoV-2 的患者的不良预后方面起着至关重要的作用。关于合并 SARS-CoV-2 肺炎的肾移植受者（KTR）免疫抑制管理的数据有限。我们报告了一例 32 岁的 KTR 发生 SARS-CoV-2 感染的病例，该患者在标准免疫抑制治疗的情况下 15 天内完全康复。
相似文献
1
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.肾移植受者 SARS-CoV-2 肺炎的免疫抑制治疗维持：一例报告。
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
2
Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report.肾移植受者新型冠状病毒（SARS-CoV-2）感染：病例报告。
Am J Transplant. 2020 Jul;20(7):1864-1868. doi: 10.1111/ajt.15897. Epub 2020 May 8.
3
COVID-19 in kidney transplant recipients.肾移植受者中的新型冠状病毒肺炎
Am J Transplant. 2020 Jul;20(7):1941-1943. doi: 10.1111/ajt.15891. Epub 2020 Apr 12.
4
Novel coronavirus 2019 pneumonia in a kidney transplant recipient.肾移植受者 2019 年新型冠状病毒肺炎。
Am J Transplant. 2020 Sep;20(9):2599-2601. doi: 10.1111/ajt.15999. Epub 2020 Jun 12.
5
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.肾移植受者长期免疫抑制后 COVID-19 肺炎的成功康复。
Am J Transplant. 2020 Jul;20(7):1859-1863. doi: 10.1111/ajt.15869. Epub 2020 Mar 31.
6
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.肾移植受者的严重 COVID-19：关注药代动力学。
Am J Transplant. 2020 Jul;20(7):1896-1901. doi: 10.1111/ajt.15943. Epub 2020 May 13.
7
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine.肾移植受者 COVID-19 肺炎成功接受托珠单抗和羟氯喹治疗。
Am J Transplant. 2020 Jul;20(7):1902-1906. doi: 10.1111/ajt.15935. Epub 2020 May 13.
8
Two distinct cases with COVID-19 in kidney transplant recipients.两例肾移植受者感染 COVID-19 的病例报告。
Am J Transplant. 2020 Aug;20(8):2269-2275. doi: 10.1111/ajt.15947. Epub 2020 May 16.
9
Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?COVID-19 于肾移植受者中的病例报告：免疫抑制是否改变临床特征？
Am J Transplant. 2020 Jul;20(7):1875-1878. doi: 10.1111/ajt.15874. Epub 2020 Apr 9.
10
Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients.实体器官移植受者 2019 冠状病毒病的临床特征和免疫抑制剂治疗。
Am J Transplant. 2020 Jul;20(7):1916-1921. doi: 10.1111/ajt.15928. Epub 2020 May 4.
引用本文的文献
1
Long COVID symptoms 6 months after acute infection among people living with HIV and people not living with HIV.HIV感染者和非HIV感染者急性感染6个月后的新冠长期症状。
Front Immunol. 2024 Nov 28;15:1430214. doi: 10.3389/fimmu.2024.1430214. eCollection 2024.
2
The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois.新型冠状病毒肺炎、结核病和艾滋病：三者之间的关系。
Front Immunol. 2023 Jan 27;14:1104828. doi: 10.3389/fimmu.2023.1104828. eCollection 2023.
3
Covid-19 in kidney transplant recipients with immunosuppressive therapy.接受免疫抑制治疗的肾移植受者中的新冠病毒 19 感染情况。
Caspian J Intern Med. 2022;13(Suppl 3):161-172. doi: 10.22088/cjim.12.4.509.
4
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements.韩国肠道疾病研究协会关于2019冠状病毒病大流行期间成人炎症性肠病临床实践的指南：专家共识声明
Intest Res. 2022 Oct;20(4):431-444. doi: 10.5217/ir.2021.00111. Epub 2022 Jan 5.
5
Renal involvement in COVID-19: focus on kidney transplant sector.COVID-19 中的肾脏受累：重点关注肾移植领域。
Infection. 2021 Dec;49(6):1265-1275. doi: 10.1007/s15010-021-01706-6. Epub 2021 Oct 5.
6
A review of the evidence for and against the use of steroids in renal transplant patients with COVID-19.关于在感染新型冠状病毒肺炎的肾移植患者中使用类固醇的支持与反对证据的综述。
Saudi Med J. 2021 Oct;42(10):1149-1152. doi: 10.15537/smj.2021.42.10.20210551.
7
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.SARS-CoV-2 在实体器官移植受者中的研究进展：2020 年的系统综述
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
8
Coronavirus disease 2019 outcomes in heart transplant recipients: a single-center case series.2019 年冠状病毒病在心脏移植受者中的结局：单中心病例系列。
J Med Case Rep. 2021 Sep 13;15(1):453. doi: 10.1186/s13256-021-03028-5.
9
The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature.COVID-19疾病肾移植受者的免疫抑制管理：文献综述与最新进展
Medicina (Kaunas). 2021 Apr 30;57(5):435. doi: 10.3390/medicina57050435.
10
Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders.炎症性眼病和自身免疫性疾病患者接种新冠疫苗的眼科考量
Ophthalmol Ther. 2021 Jun;10(2):201-209. doi: 10.1007/s40123-021-00338-1. Epub 2021 Mar 6.
本文引用的文献
1
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
2
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.COVID-19 患者的临床特征、出院率和死亡率的荟萃分析。
J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757. Epub 2020 Mar 23.
3
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
4
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
Zotero 插件